Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2005;112:2530-2537
doi: 10.1161/CIRCULATIONAHA.105.583716
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stone, G. W.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stone, G. W.
Right arrow Articles by Serruys, P. W.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Angioplasty
Related Collections
Right arrow Restenosis
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Catheter-based coronary interventions: stents
Right arrow Chronic ischemic heart disease

(Circulation. 2005;112:2530-2537.)
© 2005 American Heart Association, Inc.


New Drugs and Technologies

Percutaneous Recanalization of Chronically Occluded Coronary Arteries

A Consensus Document: Part II

Gregg W. Stone, MD; Nicolaus J. Reifart, MD; Issam Moussa, MD; Angela Hoye, MD; David A. Cox, MD; Antonio Colombo, MD; Donald S. Baim, MD; Paul S. Teirstein, MD; Bradley H. Strauss, MD, PhD; Matthew Selmon, MD; Gary S. Mintz, MD; Osamu Katoh, MD; Kazuaki Mitsudo, MD; Takahiko Suzuki, MD; Hideo Tamai, MD; Eberhard Grube, MD; Louis A. Cannon, MD; David E. Kandzari, MD; Mark Reisman, MD; Robert S. Schwartz, MD; Steven Bailey, MD; George Dangas, MD, PhD; Roxana Mehran, MD; Alexander Abizaid, MD; Jeffrey W. Moses, MD; Martin B. Leon, MD; Patrick W. Serruys, MD, PhD

From the Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY (G.W.S., I.M., G.S.M., G.D., R.M., J.W.M., M.B.L.); Kardiologisches Institut, Bad Soden, Germany (N.J.R.); Thoraxcenter, Rotterdam, the Netherlands (A.H., P.W.S.); Mid Carolina Cardiology, Charlotte, NC (D.A.C.); Columbus Hospital, Milan, Italy (A.C.); Brigham and Women’s Hospital, Boston, Mass (D.S.B.); Scripps Clinic, La Jolla, Calif (P.S.T.); St Michael’s Hospital, Toronto, Ontario, Canada (B.H.S.); Cardiovascular Medicine and Coronary Intervention, Redwood City, Calif (M.S.); Toyohashi Heart Center, Toyohashi, Aichi, Japan (O.K., T.S.); Kurashiki Central Hospital, Okayama, Japan (K.M.); Shiga Medical Center for Adults, Moriyama, Japan (H.T.); Heart Center Siegburg, Siegburg, Germany (E.G.); Cardiac and Vascular Research Center of Northern Michigan, Petoskey (L.A.C.); Duke University Medical Center, Durham, NC (D.E.K.); Swedish Medical Center, Seattle, Wash (M.R.); Minneapolis Heart Institute Foundation, Minneapolis (R.S.S.); University of Texas Health Science Center at San Antonio (S.B.); and Institute Dante Pazzanese of Cardiology, Sao Paulo, Brazil (A.A.).

Correspondence to Gregg W. Stone, MD, Columbia University Medical Center, The Cardiovascular Research Foundation, 111 E 59th St, 11th Floor, New York, NY 10022. E-mail gs2184@columbia.edu


Key Words: coronary disease • occlusion • prognosis • revascularization


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
In Part I of this article, the definitions, prevalence, and clinical presentation of chronic total occlusions (CTOs) were reviewed, the histopathology of CTOs was examined, efforts to replicate human CTOs with experimental models were appraised, and the clinical relevance and rationale for CTO revascularization were evaluated.1 In Part II, we summarize the technical approach to and outcomes after percutaneous coronary intervention (PCI) of occluded coronary arteries, describe the novel devices and drugs approved and undergoing investigation for CTO recanalization, and conclude with practical perspectives on managing the patient with 1 or more chronic coronary occlusions.


*    Outcomes After PCI of CTOs
 
Patient Selection and Revascularization Strategies
PCI of CTOs constitutes as many as 20% of all angioplasty procedures at selected centers,2 although a rate of &10% is more typical,3–6 suggesting that CTO angioplasty is attempted in 50 000 to 100 000 patients per year in the United States. Many more CTOs are present for which PCI is never attempted, representing one of the most common causes for referral to bypass surgery rather than PCI.6–8 Furthermore, a large proportion of patients with CTOs are managed medically, the prognosis of whom may vary depending on the extent of viable myocardium and ischemia, concomitant atherosclerosis in other coronary and noncoronary vascular territories, and other comorbid conditions. The decision to attempt PCI of a CTO (versus continued medical therapy or surgical revascularization) requires an individualized risk/benefit analysis, encompassing clinical, angiographic, and technical considerations. Clinically, the patient’s age, symptom severity, associated comorbidities (eg, diabetes mellitus and chronic renal insufficiency), and overall functional status are major determinants . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Eur Heart JHome page
B. K. Courtney, N. R. Munce, K. J. Anderson, A. S. Thind, G. Leung, P. E. Radau, F. S. Foster, I. A. Vitkin, R. S. Schwartz, A. J. Dick, et al.
Innovations in imaging for chronic total occlusions: a glimpse into the future of angiography's blind-spot
Eur. Heart J., March 1, 2008; 29(5): 583 - 593.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
J. M. Wilson and J. T. Willerson
Myocardial Revascularization with Percutaneous Devices
Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598.
[Full Text]


Home page
CirculationHome page
D. Locca, C. Bucciarelli-Ducci, A. La Manna, and S. Prasad
Percutaneous Coronary Intervention of Chronic Total Occlusion With Retrograde Approach: Follow-Up by Cardiac Magnetic Resonance Imaging
Circulation, July 10, 2007; 116(2): e22 - e24.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. Prasad, C. S. Rihal, R. J. Lennon, H. J. Wiste, M. Singh, and D. R. Holmes Jr
Trends in Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions: A 25-Year Experience From the Mayo Clinic
J. Am. Coll. Cardiol., April 17, 2007; 49(15): 1611 - 1618.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. S. Teirstein
The Dueling Hazards of Incomplete Revascularization and Incomplete Data
Circulation, May 23, 2006; 113(20): 2380 - 2382.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. R. Dixon, C. L. Grines, and W. W. O'Neill
The Year in Interventional Cardiology
J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1689 - 1706.
[Full Text] [PDF]


Home page
CirculationHome page
D. S. Baim and R. Y. Kwong
Is Magnetic Resonance Image Guidance the Key to Opening Chronic Total Occlusions?
Circulation, February 28, 2006; 113(8): 1053 - 1055.
[Full Text] [PDF]